Immunosenescence and influenza vaccine efficacy

Current Topics in Microbiology and Immunology

Volumn 333, Issue 1, 2009, Pages 413-429

  Sambhara, Suryaprakash ^a   McElhaney, Janet E ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CYTOKINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 6; INTERLEUKIN 8; LIVE VACCINE; PLACEBO; TOLL LIKE RECEPTOR; TRIPLE VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; AGING; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CYTOKINE RELEASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INFLUENZA; INNATE IMMUNITY; MOLECULAR MECHANICS; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REVIEW; SENESCENCE;

EID: 74049089565     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-92165-3_20     Document Type: Review

References (113)

1. Alberti S, Cevenini E et al (2006) Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans. Mech Ageing Dev 127(6):560-566
2. Andrew D, Aspinall R (2002) Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 37(2-3):455-463
3. Apasov S, Redegeld F et al. (1993) Cell-mediated cytotoxicity: contact and secreted factors. Curr Opin Immunol 5(3):404-410
4. Aw D, Silva AB et al (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120(4):435-446
5. Bi Y, Liu G et al (2007) Th17 cell induction and immune regulatory effects. J Cell Physiol 211(2):273-278
6. Bingle CD, Craven CJ (2002) PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet 11(8):937-943
7. Boucher N, Dufeu-Duchesne T et al (1998) CD28 expression in T cell aging and human longevity. Exp Gerontol 33(3):267-282
8. Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6(1):33-43
9. Buelow R, Van Schooten W (2006) The future of antibody therapy. Ernst Schering Found Symp Proc 4:83-106
10. Buxton JA, Skowronski DM et al (2001) Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks. J Infect Dis 184(2):188-191
11. Chen Z, O'Shea JJ (2008) Regulation of IL-17 production in human lymphocytes. Cytokine 41(2):71-78
12. Couch RB, Winokur P et al (2007) Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 25(44):7656-7663
13. De Bruijn IA, Remarque EJ et al (1999) Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 179(1):31-36
14. De Haan G, Van Zant G (1999) Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 93(10):3294-3301
15. Dejaco C, Duftner C et al (2006) Are regulatory T cells linked with aging? Exp Gerontol 41(4):339-345
16. Ely KH, Roberts AD et al (2007) Aging and CD8+ T cell immunity to respiratory virus infections. Exp Gerontol 42(5):427-431
17. FDA. (2007) FDA approves nasal influenza vaccine for use in younger children. http://www.fda. gov/bbs/topics/NEWS/2007/NEW01705.html. Accessed 12 Feb 2008
18. Fiore AE, Shay DK et al (2007) Prevention and control of influenza.
19. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56(RR-6):1-54
20. Fishwild DM, O'Donnell SL et al (1996) High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat Biotechnol 14(7):845-851
21. Franceschi C (2007) Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev 65(12 Pt 2):S173-S176
22. Franceschi C, Bonafe M et al (2000) Inflammaging. An evolutionary perspective on immunose-nescence. Ann N Y Acad Sci 908:244-254
23. Ganz T (2002) Epithelia: not just physical barriers. Proc Natl Acad Sci USA 99(6):3357-3358
24. Ganz T, Oren A et al (1992) Defensins: microbicidal and cytotoxic peptides of mammalian host defense cells. Med Microbiol Immunol (Berl) 181(2):99-105
25. Gardner EM, Bernstein ED et al (2001) Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine 19(32):4610-4617
26. Gardner EM, Gonzalez EW et al (2006) Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine 24(10):1609-1614
27. Ginaldi L, Loreto MF et al (2001) Immunosenescence and infectious diseases. Microbes Infect 3(10):851-857
28. Gosain A, DiPietro LA (2004) Aging and wound healing. World J Surg 28(3):321-326
29. Govaert TM, Thijs CT et al (1994) The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272(21):1661-1665
30. Gross PA (2002) Review: inactivated vaccines provide the greatest protection against influenza in healthy persons. ACP J Club 136(3):103
31. Hare KJ, Jenkinson EJ et al (2000) An essential role for the IL-7 receptor during intrathymic expansion of the positively selected neonatal T cell repertoire. J Immunol 165(5):2410-2414
32. Hartman M, Catlin A et al (2008) US health spending by age, selected years through 2004. Health Affairs 27(1):w1-w12
33. Haynes L, Eaton SM et al (2000) The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines. Vaccine 18(16):1649-1653
34. Haynes L, Eaton SM et al (2004) Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J Immunol 172(9):5194-5199
35. Hill JA, Benoist C et al (2007) Treg cells: guardians for life. Nat Immunol 8(2):124-125
36. Hoffmann JA, Kafatos FC et al (1999) Phylogenetic perspectives in innate immunity. Science 284(5418):1313-1318
37. Holmskov U, Thiel S et al (2003) Collectins and ficolins: Humoral lectins of the innate immune defense. Annu Rev Immunol 21(1):547-578
38. Htwe TH, Mushtaq A et al (2007) Infection in the elderly. Infect Dis Clin North Am 21(3):711-743
39. Huang J, Durum SK et al (2001) Cutting edge: histone acetylation and recombination at the TCR gamma locus follows IL-7 induction. J Immunol 167(11):6073-6077
40. Imler JL, Hoffmann JA (2001) Toll receptors in innate immunity. Trends Cell Biol 11(7):304-311
41. Iorio AM, Camilloni B et al (2007) Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Gerontology 53(6):411-418
42. Jiang J, Gross D et al (2007) Aging affects initiation and continuation of T cell proliferation. Mech Ageing Dev 128(4):332-339
43. Kang DC, Gopalkrishnan RV et al (2002) Mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA 99(2):637-642
44. Keitel WA, Atmar RL et al (2006) Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 166(10):1121-1127
45. Kovaiou RD, Herndler-Brandstetter D et al (2007) Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med 9(3):1-17
46. Kuroiwa Y, Kasinathan P et al (2002) Cloned transchromosomic calves producing human immu-noglobulin. Nat Biotechnol 20(9):889-894
47. Lamberts SW, Van Den Beld AW et al (1997) The endocrinology of aging. Science 278(5337):419-424
48. Lanzavecchia A, Corti D et al (2007) Human monoclonal antibodies by immortalization of memory B cells 88. Curr Opin Biotechnol. 18(6):523-528
49. Laube S (2004) Skin infections and ageing. Ageing Res Rev 3(1):69-89
50. Leroux-Roels I, Borkowski A et al (2007) Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 370(9587):580-589
51. Liang Y, Van G Zant et al (2005) Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 106(4):1479-1487
52. Linton PJ, Li SP et al (2005) Intrinsic versus environmental influences on T cell responses in aging. Immunol Rev 205(1):207-219
53. Lu J, Teh C et al (2002) Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 1572(2-3):387-400
54. Lung TL, Saurwein-Teissl M et al (2000) Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18(16):1606-1612
55. Martinon F, Tschopp J (2005) NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26(8):447-454
56. Martz E, Burakoff SJ et al (1974) Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T cells or complement. Proc Natl Acad Sci USA 71(1):177-181
57. McElhaney JE, Pinkoski MJ et al (1996) The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity. J Immunol Methods 190(1):11-20
58. McElhaney JE, Xie D et al (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176(10):6333-6339
59. Medzhitov R, Janeway C Jr (2000a) Innate immune recognition: mechanisms and pathways. Immunol Rev 173:89-97
60. Medzhitov R, Janeway C Jr (2000b) Innate immunity. N Engl J Med 343(5):338-344
61. Meyer KC (2001) The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol 128(1):23-31
62. Meyer KC (2004) Lung infections and aging. Ageing Res Rev 3(1):55-67
63. Meyer KC (2005) Aging. Proc Am Thorac Soc 2(5):433-439
64. Meyer KC, Ershler W et al (1996) Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 153(3):1072-1079
65. Meyerson LB (1966) Aging and the skin. Ohio State Med J 62(5):453-456
66. Miller RA (1996) The aging immune system: primer and prospectus. Science 273(5271):70-74
67. Miller RA (1997) The aging immune system: subsets, signals, and survival. Aging (Milano) 9(4):23-24
68. Nakae S, Iwakura Y et al (2007) Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 81(5):1258-1268.
69. National Center for Health Statistics (2003) Early release of selected estimates based on data from the January-September National Health Interview Survey (NHIS). http://www.cdc.gov/nchs/ about/major/nhis/released200303.htm#5. Accessed on 10, March 2008
70. Nichol KL, Nordin JD et al (2007) Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357(14):1373-1381
71. Ortman CL, Dittmar KA et al (2002) Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int Immunol 14(7):813-822
72. Plowden J, Renshaw-Hoelscher M et al (2004a) Innate immunity in aging: impact on macrophage function. Aging Cell 3(4):161-167
73. Plowden J, Renshaw-Hoelscher M et al (2004b) Impaired antigen-induced CD8(+) T cell clonal expansion in aging is due to defects in antigen presenting cell function. Cell Immunol 229(2):86-92
74. Podda A, Del Giudice G (2003) MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile. Expert Rev Vaccines 2(2):197-203
75. Reed MJ, Koike T et al (2003) Wound repair in aging. A review. Methods Mol Med 78:217-237
76. Renshaw M, Rockwell J et al (2002) Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 169(9):4697-4701
77. Rizzo C, Viboud C et al (2006) Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 24(42-43):6468-6475
78. Sambhara S, Kurichh A et al (1998) Enhanced immune responses and resistance against infection in aged mice conferred by Flu-ISCOMs vaccine correlate with up-regulation of costimulatory molecule CD86. Vaccine 16(18):1698-1704
79. Sambhara S, Kurichh A et al (2001) Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses. Cell Immunol 210(1):1-4
80. Sambhara S, Poland GA (2007) Breaking the immunogenicity barrier of bird flu vaccines. Lancet 370(9587):544-545
81. Sansoni P, Vescovini R et al (2008) The immune system in extreme longevity. Exp Gerontol 43(2):61-65
82. Schittek B, Hipfel R et al (2001) Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2(12):1133-1137
83. Sebastian C, Espia M et al (2005) MacrophAging: a cellular and molecular review. Immunobiology 210(2-4):121-126
84. Shay K, Ship JA (1995) The importance of oral health in the older patient. J Am Geriatr Soc 43(12):1414-1422
85. Simmons CP, Bernasconi NL et al (2007) Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza 362. PLoS Med 4(5):e178
86. Simonsen L, Reichert TA et al (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165(3):265-272
87. Simonsen L, Taylor RJ et al (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7(10):658-666
88. Smith NM, Shay DK (2006) Influenza vaccination for elderly people and their care workers. Lancet 368(9549):1752-1753
89. Sobel JD (1997) Pathogenesis of urinary tract infection. Role of host defenses. Infect Dis Clin North Am 11(3):531-549
90. Sorensen OE, Cowland JB et al (2003) Wound healing and expression of antimicrobial peptides/ polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170(11):5583-5589
91. Takaoka A, Wang Z et al (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-505
92. Tesar BM, Walker WE et al (2006) Murine myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging. Aging Cell 5(6):473-486
93. World Health Organization (2008) Influenza. http://www.who.int/ mediacentre/factsheets/fs211/ en/. Accessed 12 Feb 2008
94. Thomas DR (2001) Age-related changes in wound healing. Drugs Aging 18(8):607-620
95. Thompson WW, Shay DK et al (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289(2):179-186
96. Thompson WW, Shay DK et al (2004) Influenza-associated hospitalizations in the United States. JAMA 292(11):1333-1340
97. Ting JP, Davis BK (2005) CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 23:387-414
98. Tomizuka K, Shinohara T et al (2000) Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies. Proc Natl Acad Sci \USA 97(2):722-727
99. Traggiai E, Becker S et al (2004) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 10(8):871-875
100. Treanor JJ, Schiff GM et al (2006) Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis 193(9):1223-1228
101. Treanor JJ, Schiff GM et al (2007) Safety and immunogenicity of a baculovirus-expressed hemag-glutinin influenza vaccine: a randomized controlled trial. JAMA 297(14):1577-1582
102. Van Den Biggelaar AH, Huizinga TW et al (2004) Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol 39(9):1407-1414
103. Van Duin D, Shaw AC (2007) Toll-like receptors in older adults. J Am Geriatr Soc 55(9):1438-1444
104. Van Duin D, Allore HG et al (2007a) Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis 195(11):1590-1597
105. Van Duin D, Mohanty S et al (2007b) Age-associated defect in human TLR-1/2 function. J Immunol 178(2):970-975
106. Vu T, Farish S et al (2002) A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20(13-14):1831-1836
107. Wang CQ, Udupa KB et al (1995) Effect of age on marrow macrophage number and function. Aging (Milano) 7(5):379-384
108. Wood J, Schild G et al (1997) Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines. Dev Biol Stand 39:193-200
109. Worley CA (2006) Aging skin and wound healing. Dermatol Nurs 18(3):265-266
110. Yap KL, Ada GL et al (1978) Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273:413-420
111. Yoneyama M, Kikuchi M et al (2004) Th.e RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730-737
112. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75(1):39-48
113. Zhao L, Sun L et al (2007) Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice. J Leukoc Biol 81(6):1386-1394